{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pathogenesis and Role of Serous Tubal Intraepithelial Carcinoma in the Development of Ovarian Cancers

Activity Steps

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Stratify patients into high- and low-risk groups for the development of pelvic serous carcinoma.
  2. Identify the characteristics of serous tubal intraepithelial carcinoma, secretory cell outgrowths, p53 signatures, and pelvic serous carcinoma.
  3. Counsel high- and low-risk patients on the risks and benefits of salpingectomy.
Price: $49.00

Credits:

  • ACCME 1.5 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: PGO0114B
Published: January 2014
Expires: 1/1/2026
Required Passing Score: 7/10 (70%)
Authors: Anne Hutchinson, BA, Raffi A. Chalian, MD, and Norman G. Rosenblum, MD, PhD
Specialties: OB/GYN, Oncology, Surgery